Skip to main content

Peer Review reports

From: Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial

Original Submission
5 Feb 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
11 Mar 2021 Reviewed Reviewer Report
17 Mar 2021 Reviewed Reviewer Report
5 Apr 2021 Author responded Author comments - Xiaoqiang Zhang
Resubmission - Version 3
5 Apr 2021 Submitted Manuscript version 3
6 Apr 2021 Author responded Author comments - Xiaoqiang Zhang
Resubmission - Version 4
6 Apr 2021 Submitted Manuscript version 4
12 Apr 2021 Reviewed Reviewer Report
26 Apr 2021 Reviewed Reviewer Report
4 May 2021 Author responded Author comments - Xiaoqiang Zhang
Resubmission - Version 5
4 May 2021 Submitted Manuscript version 5
Publishing
6 May 2021 Editorially accepted
20 May 2021 Article published 10.1186/s12871-021-01373-y

You can find further information about peer review here.

Back to article page